Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms: HELP
Articles by B. Liu
Based on 2 articles published since 2010
(Why 2 articles?)
||||

Between 2010 and 2020, B. Liu wrote the following 2 articles about Pancreatic Neoplasms.
 
+ Citations + Abstracts
1 Article [The clinical impact of artery-first approach combined with vascular resection and reconstruction in the treatment of pancreatic head carcinoma]. 2017

Huang, J L / Li, W G / Chen, F Z / Su, Z J / Li, F M / Liu, B. ·Department of Hepatobiliary Surgery, Chenggong Hospital Affiliated to Xiamen University, Xiamen Key Laboratory of biliary tract diseases, Xiamen 361000, China. ·Zhonghua Zhong Liu Za Zhi · Pubmed #28316225.

ABSTRACT:

2 Article Percutaneous computed tomography-guided iodine-125 seeds implantation for unresectable pancreatic cancer. 2015

Liu, B / Zhou, T / Geng, J / Zhang, F / Wang, J / Li, Y. ·Department of Interventional Medicine, The Second Hospital of Shandong University, Shandong, Shandong Province, PR of, China. ·Indian J Cancer · Pubmed #26728678.

ABSTRACT: BACKGROUND: To examine the safety and clinical efficacy of computed tomography (CT)-guided radioactive iodine-125 (125I) seeds implantation for patients with unresectable pancreatic cancer. MATERIALS AND METHODS: A group of 26 patients with pathologically confirmed unresectable pancreatic cancer underwent percutaneous CT-guided 125I seeds implantation. Part of them received transarterial chemotherapy and/or percutaneous transhepatic cholangial drainage before or after seeds implantation. The primary endpoints were the objective response rates, local control rates, and overall survival. RESULTS: CT scan 2 months after treatment revealed complete response (CR) in 8 patients, partial response (PR) in 9 patients. Overall response rate (CR + PR) is 65.38%. Local control rate was 88.46%. Median survival of the whole group was 15.3 months, whereas for Stage III and IV was 17.6 and 9.1 months, respectively. The estimated 1-year survival was 30.77%. CONCLUSIONS: We consider CT-guided 125I seeds implantation as a safe, effective, uncomplicated treatment for unresectable pancreatic cancer.